Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -41,820 | -122,993 | -100,672 | -69,950 | -34,891 |
| Depreciation Amortization | 1,232 | 3,998 | 2,887 | 1,806 | 744 |
| Income taxes - deferred | N/A | -12,661 | -8,652 | -8,652 | -8,652 |
| Accounts receivable | 343 | 166 | -3,105 | 2,478 | -1,241 |
| Accounts payable and accrued liabilities | 9,382 | -11,875 | -11,738 | -22,269 | -24,703 |
| Other Working Capital | -9,261 | -65,314 | -54,563 | -47,662 | -47,029 |
| Other Operating Activity | -6,651 | 23,285 | 24,160 | 26,528 | 30,276 |
| Operating Cash Flow | $-46,775 | $-185,394 | $-151,683 | $-117,721 | $-85,496 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 7,103 | 50,750 | 186,512 | 99,404 | 42,547 |
| PPE Investments | -40 | -228 | -224 | -163 | -92 |
| Investing Cash Flow | $7,063 | $50,522 | $186,288 | $99,241 | $42,455 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 145,905 | N/A | N/A | N/A |
| Debt Repayment | -581 | -2,280 | -1,714 | -1,162 | -536 |
| Common Stock Issued | 25 | 7,987 | 5,481 | 5,427 | 1,111 |
| Common Stock Repurchased | -972 | -1,679 | -1,679 | -1,679 | -1,679 |
| Financing Cash Flow | $-1,528 | $149,933 | $2,088 | $2,586 | $-1,104 |
| Beginning Cash Position | 61,661 | 46,600 | 46,600 | 46,600 | 46,600 |
| End Cash Position | 20,421 | 61,661 | 83,293 | 30,706 | 2,455 |
| Net Cash Flow | $-41,240 | $15,061 | $36,693 | $-15,894 | $-44,145 |
| Free Cash Flow | |||||
| Operating Cash Flow | -46,775 | -185,394 | -151,683 | -117,721 | -85,496 |
| Capital Expenditure | -40 | -228 | -224 | -163 | -92 |
| Free Cash Flow | -46,815 | -185,622 | -151,907 | -117,884 | -85,588 |